Repeated botulinum toxin A injections for the treatment of lines in the upper face: A retrospective study of 4,103 treatments in 945 patients

Dermatologic Surgery

Volumn 33, Issue SUPPL. 1, 2007, Pages

  Rzany, Berthold ^a   Dill Müller, Dorothee ^b   Grablowitz, Doris ^c   Heckmann, Marc ^d   Caird, David ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c Dermatologisch Medizinisch Ästhetisches Zentrum   (Austria)

^d Hautzentrum am Starnberger See   (Germany)

^e IDS SCHEER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CAPILLARY RESISTANCE; CONTROLLED STUDY; ESTHETICS; FACE; FEMALE; HUMAN; MEDICAL RECORD REVIEW; PHYSICAL ATTRACTIVENESS; PRIORITY JOURNAL; PTOSIS; RETROSPECTIVE STUDY; SKIN MANIFESTATION; WRINKLE;

ADULT; BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; EYEBROWS; FACE; FEMALE; HUMANS; INJECTIONS; MIDDLE AGED; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES;

EID: 33846002044     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32327.x     Document Type: Article

References (16)

1. Heckmann M, Teichmann B, Schroder U, et al. Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear. J Am Acad Dermatol 2003;49:213-6.
2. Klein AW. Contraindications and complications with the use of botulinum toxin. Clin Dermatol 2004;22:66-75.
3. Markey AC. Dysport. Dermatol Clin 2004;22:213-9.
4. Feller G, Bayerl C, Jung E, Rzany B. Korrektur der dynamischen Gesichtsfallen mit botulinumtoxin A (Dysport). Aktuelle Dermatol 2000;26:65-9.
5. Rzany B, Becker-Wegerich P, Hiepe-Wegener D, et al. Botulinum toxin A in aesthetic dermatology. Kosmet Med 2003;24:72-9.
6. Rzany B, Fratila A, Heckmann M. Second expert meeting on the use of botulinum toxin A (Dysport) in aesthetic dermatology. Kosmet Med 2005;3:34-41.
7. Ascher B, Zakine B, Kestemont P, et al. Botulinum toxin A in the treatment of glabellar lines: scheduling the next injection. Aesthetic Surg J 2005;25:365-75.
8. Ascher B, Zakine B, Kestemont P, et al. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. J Am Acad Dermatol 2004;51:223-33.
9. Rzany B, Ascher B, Fratila A, et al. Efficacy and safety of 3- and 5-injection patterns (30 and 50U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region. Arch Dermatol 2006;142:320-6.
10. Monheit G, Carruthers A, Brandt F, Rand R. A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose. Dermatol Surg 2007;33(Suppl 1):51-59.
11. Bulstrode NW, Grobbelaar AO. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides. Aesthetic Plast Surg 2002;26:356-9.
12. Carruthers A, Carruthers J. Long-term safety review of subjects treated with botulinum toxin type A (BoNT/A) for cosmetic use. From the 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins; 2005 Jun 23-25; Denver, CO. p. P03.
13. Kessler KR, Skutta M, Benecke R. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. J Neurol 1999;246:265-74.
14. Haussermann P, Marczoch S, Klinger C, et al. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A. Mov Disord 2004;19:303-8.
15. Carruthers A, Carruthers J. History of the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998;24:1168-70.
16. Cote TR, Mohan AK, Polder JA, et al. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 2005;53:407-15.